Douglas Murphy-Chutorian - 17 Nov 2025 Form 4 Insider Report for Semler Scientific, Inc. (SMLR)

Signature
/s/ Douglas Murphy-Chutorian
Issuer symbol
SMLR
Transactions as of
17 Nov 2025
Transactions value $
-$1,143,858
Form type
4
Filing time
18 Nov 2025, 16:05:17 UTC
Previous filing
26 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Murphy-Chutorian Douglas CEO, interim CFO and Director, Director C/O SEMLER SCIENTIFIC, INC., 51 E. CAMPBELL AVENUE, SUITE 107-D, CAMPBELL /s/ Douglas Murphy-Chutorian 18 Nov 2025 0001594342

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMLR Common Stock Options Exercise $278,750 +125,000 $2.23 125,000 17 Nov 2025 Direct
transaction SMLR Common Stock Sale -$1,158,570 -57,669 -46% $20.09 67,331 17 Nov 2025 Direct F1, F2
transaction SMLR Common Stock Sale -$264,038 -12,737 -19% $20.73 54,594 17 Nov 2025 Direct F1, F3
transaction SMLR Common Stock Gift $0 -54,594 -100% $0 0 17 Nov 2025 Direct F4
transaction SMLR Common Stock Gift $0 +54,594 +29% $0 241,303 17 Nov 2025 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMLR Stock Option (right to buy) Options Exercise $0 -125,000 -100% $0 0 17 Nov 2025 Common Stock 125,000 $2.23 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to cover the exercise price and withholding taxes.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.57 to $20.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.57 to $21.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding, the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F4 Shares are held in a family trust over which Dr. Murphy-Chutorian is co-Trustee with his spouse, and with whom he shares voting and investment power over such securities.
F5 The shares underlying the option are fully vested and immediately exercisable.